HomeANNX • STO
add
Annexin Pharmaceuticals AB (publ)
Previous close
kr 0.46
Day range
kr 0.44 - kr 0.52
Year range
kr 0.19 - kr 0.93
Market cap
255.87M SEK
Avg Volume
297.76K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.99M | 3.00% |
Net income | -10.93M | -0.85% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -10.94M | -3.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.64M | 126.80% |
Total assets | 28.60M | 78.90% |
Total liabilities | 3.51M | -77.12% |
Total equity | 25.08M | — |
Shares outstanding | 532.98M | — |
Price to book | 9.24 | — |
Return on assets | -78.52% | — |
Return on capital | -89.93% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.93M | -0.85% |
Cash from operations | -11.69M | -6.50% |
Cash from investing | — | — |
Cash from financing | -24.00K | -100.48% |
Net change in cash | -11.71M | -96.02% |
Free cash flow | -7.63M | 35.78% |
About
Founded
2014
Website
Employees
4
